Lilly and Incyte highlight positive data for Olumiant in rheumatoid arthritis
The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today positive data for Olumiant® (baricitinib) will be presented at ...
ADVERTISEMENT
Tag: lly
Lilly to acquire Disarm Therapeutics
THe FINANCIAL -- Eli Lilly and Company (NYSE: LLY) announced a definitive agreement to acquire Disarm Therapeutics, a privately-held biotechnology company ...
ADVERTISEMENT
Popular Last 24h
-
Quantum Computing, Inc. Announces Private Placement of Common Stock for Proceeds of $100 Million
-
Crews battle fire at Cleveland Metroparks Zoo’s Rainforest exhibit
-
Rodrigo Bentancur needed stretchering off after a sickening head injury
-
The UK Government has announced a full asset freeze against Blood and Honour.
-
SAG Awards 2025 Nominations
-
Why Enterprises Need AI Query Engines to Fuel Agentic AI
-
Justice Department Files Voting Rights Suit Against City of Hazleton, Pennsylvania
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
